CENTURY(SZ:300078)2016-05-25 16:00Dividend Distribution - The company plans to distribute a cash dividend of 0.5 RMB per 10 shares to all shareholders, based on a total share capital of 418,750,000 shares as of December 31, 2015[5]. - The board of directors has approved the profit distribution plan, which includes no bonus shares and no capital reserve conversion[5]. - The cash dividend policy was compliant with the company's articles of association and was clearly defined, ensuring the protection of minority shareholders' rights[125]. - The cash dividend payout ratio for 2015 was 100% of the distributable profit[126]. - The company distributed a cash dividend of RMB 0.5 per 10 shares, totaling RMB 20,937,500 for the year 2015, which represents 14.85% of the net profit attributable to shareholders[130]. - The cash dividend for 2014 was RMB 8,375,000, which was 10.74% of the net profit attributable to shareholders for that year[131]. - The company has maintained a consistent dividend distribution policy over the past three years, with a total cash dividend of RMB 83,750,000 in 2013[131]. Financial Performance - The company's operating revenue for 2015 was ¥852,947,002.75, representing a 73.65% increase compared to ¥491,174,772.71 in 2014[19]. - The net profit attributable to shareholders for 2015 was ¥140,968,241.51, an increase of 80.80% from ¥77,968,136.51 in 2014[19]. - The net cash flow from operating activities reached ¥162,868,031.86, a significant increase of 230.04% compared to ¥49,348,260.90 in 2014[19]. - The total assets at the end of 2015 amounted to ¥2,456,940,737.01, reflecting a 92.11% increase from ¥1,278,897,958.37 at the end of 2014[19]. - The basic earnings per share for 2015 was ¥0.34, up 78.95% from ¥0.19 in 2014[19]. - The weighted average return on equity for 2015 was 11.58%, an increase of 4.81% from 6.77% in 2014[19]. - The company reported a net profit excluding non-recurring gains and losses of ¥110,200,205.32, a 64.34% increase from ¥67,055,143.41 in 2014[19]. Business Expansion and Strategy - The company is focused on expanding its market presence and enhancing its product offerings in the RFID and EAS sectors[10]. - The company is investing in new product development and technological advancements to maintain competitive advantage in the healthcare technology sector[10]. - The company is exploring potential mergers and acquisitions to accelerate growth and expand its service capabilities[10]. - The company aims to leverage big data and cloud computing technologies to enhance operational efficiency and customer experience[10]. - The company has expanded its business into the smart healthcare sector, enhancing its core competitiveness through significant asset acquisitions[29]. - The company has established three main business segments: smart healthcare, EAS, and RFID, targeting various industries including retail and healthcare[30][31]. - The company is actively pursuing strategic partnerships and potential acquisitions to enhance its market position[186]. Research and Development - The company continues to focus on innovation, with multiple new software and patent registrations aimed at enhancing its product offerings in the healthcare technology space[38]. - In 2015, the company achieved significant progress in R&D, obtaining 38 software copyrights and achieving CMMI Level 5 certification, indicating its software process capabilities meet international standards[50]. - Research and development (R&D) investment reached ¥51,587,668.56, representing 6.05% of operating income, with a significant increase in R&D personnel to 572, up from 260 in the previous year[80]. - The company plans to strengthen its research and development efforts in 2016, focusing on new product development in medical health information consumables and building a medical ecological cloud platform[114]. Acquisitions and Investments - The company acquired 100% equity of Yihui Technology, significantly enhancing its competitiveness in the smart healthcare sector[34]. - The company completed the acquisition of 100% equity in Medical Technology Co., Ltd. for CNY 1.08724 billion, enhancing its capabilities in the smart medical sector[44]. - The company committed to a profit guarantee for Medical Information Technology, ensuring net profits of no less than RMB 70 million, RMB 95 million, and RMB 120 million for the years 2015, 2016, and 2017 respectively[134]. - The company reported an actual performance of RMB 78.6854 million for the profit guarantee period, exceeding the forecast of RMB 70 million[134]. - The company has faced challenges in project implementation due to the complex changes in the global economic environment, affecting market demand[95]. - The company has reported a delay in the construction of the factory for the RFID system and equipment production project, impacting project benefits realization[95]. Market Presence and Sales - The company reported a significant increase in user data and engagement metrics, reflecting a growing customer base and market penetration[10]. - The RFID business experienced significant growth due to increased market demand, particularly in the international apparel retail sector[43]. - The company actively expanded its market presence in the apparel and jewelry retail sectors, successfully establishing partnerships with several well-known enterprises[56]. - Domestic sales surged by 351.13%, reaching ¥392,797,544.18, while international sales increased by 13.87% to ¥460,149,458.57[67]. - The revenue from the RFID and other segments saw a significant increase of 176.63%, amounting to ¥196,010,903.25, up from ¥70,856,973.98 in the previous year[66]. Corporate Governance and Management - The company is committed to maintaining transparency and accuracy in its financial reporting and disclosures[4]. - The management team was restructured to improve operational management, with key appointments from Yihui Technology to strengthen the integration of existing EAS and RFID businesses[35]. - The company has maintained a stable ownership structure with no reported changes in the actual controller's status[178]. - The company has a structured approach to determining the remuneration of its directors and senior management based on their work capabilities and performance[195]. - The company has received multiple awards for its contributions to technology and innovation in the healthcare industry[186]. Challenges and Risks - The company is facing potential risks from intensified market competition in the smart healthcare sector, as more firms enter the medical information technology space[118]. - The company recognized goodwill of ¥649.9 million from the acquisition, which poses a risk of impairment if the acquired entity does not meet expected performance[119]. - The company has a pending non-public stock issuance that requires approval from the China Securities Regulatory Commission, which introduces uncertainty regarding funding and financial costs[121]. Employee and Director Information - The total remuneration paid to all current and former directors, supervisors, and senior management in 2015 amounted to CNY 4.4575 million[196]. - The highest remuneration among the current directors was received by Mr. Zhang Ji, totaling CNY 568,100[198]. - The total number of employees in the company is 1,530, with 300 in the parent company and 1,230 in major subsidiaries[199]. - The educational background of employees shows that 702 have a university degree or above, 405 have a college degree, 204 have a high school or vocational education, and 219 have education below junior high school[199].